Fenimore Christopher R. 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2024/8/29 申報
- 申報編號
- 0001883850-24-000045
- 申報時間
- 2024/8/29
- 交易日
- 2024/8/28
- 申報延遲
- 1 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $684.6 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Fenimore Christopher R.CIK 0001697422 | 高階主管（SVP Finance & CFO） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/8/28 | Common Stock | S賣出處分 | −228 | $1,204.79F1 | −$274,692.12 | 966 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −766 | $1,205.44F2 | −$923,367.04 | 200 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −200 | $1,206.30F3 | −$241,260 | 0 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −2,237 | $1,204.71F4 | −$2,694,936.27 | 1,378 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −928 | $1,205.49F5 | −$1,118,694.72 | 450 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −450 | $1,206.15F6 | −$542,767.5 | 0 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −236 | $1,205.67F7 | −$284,538.12 | 225 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −200 | $1,206.70F8 | −$241,340 | 25 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −235 | $1,205.67F9 | −$283,332.45 | 225 | 間接 | |
| 2024/8/28 | Common Stock | S賣出處分 | −200 | $1,206.67F10 | −$241,334 | 25 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。